ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,283,159 | -11.4% | 47,279 | +0.4% | 0.03% | -10.3% |
Q2 2023 | $1,448,211 | -16.6% | 47,112 | -2.3% | 0.03% | -27.5% |
Q1 2023 | $1,736,917 | -3.6% | 48,207 | +5.8% | 0.04% | -20.0% |
Q4 2022 | $1,801,150 | -2.1% | 45,576 | -0.4% | 0.05% | 0.0% |
Q3 2022 | $1,839,000 | -4.0% | 45,766 | +0.4% | 0.05% | -13.8% |
Q2 2022 | $1,916,000 | +7.8% | 45,575 | -0.1% | 0.06% | +38.1% |
Q1 2022 | $1,778,000 | -2.2% | 45,641 | +0.1% | 0.04% | 0.0% |
Q4 2021 | $1,818,000 | +7.0% | 45,612 | -3.0% | 0.04% | -6.7% |
Q3 2021 | $1,699,000 | -9.0% | 47,027 | +3.2% | 0.04% | -18.2% |
Q2 2021 | $1,868,000 | -6.0% | 45,561 | -0.0% | 0.06% | -32.9% |
Q1 2021 | $1,988,000 | -12.8% | 45,579 | +0.1% | 0.08% | -18.8% |
Q4 2020 | $2,280,000 | – | 45,550 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |